• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Herbalife Completes $1.45 Billion Senior Secured Refinancing

    4/29/26 4:15:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care
    Get the next $HLF alert in real time by email

    Strategic Refinancing Expected to Result in Approximately $45 Million in Annual Cash Interest Savings1

    Herbalife Ltd. (NYSE:HLF) (the "Company"), a premier health and wellness company, community and platform, today announced the closing of the previously announced private offering by HLF Financing SaRL, LLC and Herbalife International, Inc. (together, the "Issuers"), each a wholly owned subsidiary of the Company, of $800 million aggregate principal amount of 7.750% senior secured notes due in May 2033 ("2033 Secured Notes"). Concurrently with the issuance of the 2033 Secured Notes, the Company amended its 2024 senior secured credit facility ("2024 Credit Facility"). The amendments to the 2024 Credit Facility (as amended, the "2026 Credit Facility"), among other things, refinanced and replaced in full the 2024 Credit Facility with a $225 million senior secured Term Loan A ("2026 Term Loan A") and a $425 million senior secured revolving credit facility ("2026 Revolving Credit Facility"), both maturing in April 2031.

    "We are pleased to have completed this refinancing amid significant market volatility, further improving our capital structure and reinforcing the strength of our balance sheet," said Chief Financial Officer John DeSimone. "The transaction meaningfully reduces our borrowing costs, is expected to result in approximately $45 million in annual cash interest savings1, extends our maturity profile, and provides additional financial flexibility moving forward."

    The Company used the net proceeds from these transactions, including borrowings under the 2026 Revolving Credit Facility, and available cash, to repay the $365 million outstanding principal balance on its 2024 Term Loan B and to fully redeem the $800 million outstanding principal balance of the Issuers' 12.250% senior secured notes due 2029 ("2029 Secured Notes"), plus accrued and unpaid interest, and to pay related fees and expenses.

    The 2029 Secured Notes were redeemed at 106.125% of principal. No early termination penalties were incurred in connection with the refinancing, other than the call premium reflected in the redemption price of the 2029 Secured Notes. Upon completion of the refinancing transactions, approximately $200 million was outstanding under the 2026 Revolving Credit Facility as of April 29, 2026.

    The 2033 Secured Notes were issued at a price to the public of 100.00% of par and are non-callable for three years. The 2033 Secured Notes have a fixed annual interest rate of 7.750%, which will be paid semi-annually in arrears on May 1 and November 1 of each year, commencing on November 1, 2026.

    The 2026 Term Loan A was issued at 100.0% of par and requires quarterly payments equal to 5.0% of the aggregate principal amount of the 2026 Term Loan A per annum, commencing with the quarter ending September 30, 2026. The 2026 Term Loan A and 2026 Revolving Credit Facility will initially bear interest at a per annum rate equal to SOFR plus 3.00% and will fluctuate depending on the Company's total leverage ratio at a spread ranging from SOFR plus 2.50% to SOFR plus 3.25%. Total leverage ratio is defined as consolidated total debt to consolidated EBITDA as calculated under the 2026 Credit Facility.

    The 2026 Term Loan A and 2026 Revolving Credit Facility require the Company to maintain a maximum total leverage ratio of 4.0x, a maximum first lien net leverage ratio of 2.5x and a minimum fixed charge coverage ratio of 2.0x.

    The 2033 Secured Notes and 2026 Credit Facility will be guaranteed on a senior secured basis by the Company and certain of its existing and future domestic and foreign subsidiaries.

    This press release is neither an offer to sell nor a solicitation of an offer to buy the 2033 Secured Notes, nor shall there be any sale of the 2033 Secured Notes in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction. Any offer, if at all, will be made only pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act. The 2033 Secured Notes have not been and are not expected to be registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

    About Herbalife Ltd.

    Herbalife (NYSE:HLF) is a premier health and wellness company, community and platform that has been changing people's lives with great nutrition products and a business opportunity for its independent distributors since 1980. The Company offers science-backed products to consumers in more than 90 markets through entrepreneurial distributors who provide one-on-one coaching and a supportive community that inspires their customers to embrace a healthier, more active lifestyle to live their best life.

    For more information, visit https://ir.herbalife.com.

    Forward-Looking Statements

    This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws, including any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management, including for future operations, capital expenditures, or share repurchases; any statements concerning proposed new products, services, or developments; any statements regarding future economic conditions or performance; any statements of belief or expectation; and any statements of assumptions underlying any of the foregoing or other future events. Forward-looking statements may include, among others, the words "may," "will," "estimate," "intend," "continue," "believe," "expect," "anticipate" or any other similar words.

    Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results or outcomes could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include the following:

    • the potential impacts of current global economic conditions, including inflation, unfavorable foreign exchange rate fluctuations, and tariffs or retaliatory tariffs, on us; our Members, customers, and supply chain; and the world economy;
    • our ability to attract and retain Members;
    • our relationship with, and our ability to influence the actions of, our Members;
    • our noncompliance with, or improper action by our employees or Members in violation of, applicable U.S. and foreign laws, rules, and regulations;
    • adverse publicity associated with our Company or the direct-selling industry, including our ability to comfort the marketplace and regulators regarding our compliance with applicable laws;
    • changing consumer preferences and demands and evolving industry standards, including with respect to climate change, sustainability, and other environmental, social, and governance matters;
    • the competitive nature of our business and industry;
    • legal and regulatory matters, including regulatory actions concerning, or legal challenges to, our products or network marketing program and product liability claims;
    • the Consent Order entered into with the Federal Trade Commission, or FTC, the effects thereof and any failure to comply therewith;
    • risks associated with operating internationally and in China;
    • our ability to execute our growth and other strategic initiatives (such as restructuring efforts, increased market penetration in existing markets, and personalized product and related technology initiatives);
    • the effectiveness and acceptance of new technology-driven initiatives;
    • any material disruption to our business caused by natural disasters, other catastrophic events, acts of war or terrorism, including the wars in Ukraine and the Middle East, cybersecurity incidents, pandemics, and/or other acts by third parties;
    • our ability to adequately source ingredients, packaging materials, and other raw materials and manufacture and distribute our products;
    • our reliance on our information technology infrastructure, and our ability to successfully develop, deploy, and integrate artificial intelligence into our business;
    • noncompliance by us or our Members with any privacy, artificial intelligence and data protection laws, rules, or regulations or any security breach involving the misappropriation, loss, or other unauthorized use or disclosure of confidential information;
    • contractual limitations on our ability to expand or change our direct-selling business model;
    • the sufficiency of our trademarks and other intellectual property;
    • product concentration;
    • our reliance upon, or the loss or departure of any member of, our senior management team;
    • our ability to integrate and capitalize on acquisition transactions;
    • restrictions imposed by covenants in the agreements governing our indebtedness;
    • risks related to our convertible notes;
    • changes in, and uncertainties relating to, the application of transfer pricing, income tax, customs duties, value added taxes, and other tax laws, treaties, and regulations, or their interpretation;
    • our incorporation under the laws of the Cayman Islands; and
    • share price volatility related to, among other things, speculative trading and certain traders shorting our common shares.

    Additional factors and uncertainties that could cause actual results or outcomes to differ materially from our forward-looking statements are set forth in the Company's filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the Securities and Exchange Commission on February 18, 2026, including under the headings "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" and in our Consolidated Financial Statements and the related Notes included therein. In addition, historical, current, and forward-looking sustainability-related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future.

    Forward-looking statements made in this release speak only as of the date hereof. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.

    ____________________

    1 Estimated annual cash interest savings were calculated based on total senior secured debt outstanding as of April 29, 2026, before and after the refinancing, and current applicable interest rates

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260429284494/en/

    Media Contact:

    Miguel Lopez-Najera

    Director, Global Corporate Communications

    miguellope@herbalife.com

    Investor Contact:

    Erin Banyas

    Vice President, Head of Investor Relations

    erinba@herbalife.com

    Get the next $HLF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HLF

    DatePrice TargetRatingAnalyst
    1/6/2026$20.00Buy
    Maxim Group
    11/26/2025Hold → Buy
    Argus
    3/21/2025$7.50 → $14.00Neutral → Buy
    DA Davidson
    8/1/2024$16.00 → $17.00Buy
    B. Riley Securities
    9/14/2023$13.50Neutral
    DA Davidson
    6/7/2023$13.00Neutral
    Mizuho
    2/3/2023$14.00Underperform
    BofA Securities
    7/12/2022$26.00Hold → Buy
    Jefferies
    More analyst ratings

    $HLF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cloud Lynda bought $152,490 worth of shares (17,000 units at $8.97), increasing direct ownership by 78% to 38,857 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    11/20/25 8:41:01 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $23,572 worth of shares (3,143 units at $7.50), increasing direct ownership by 2% to 170,000 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    6/9/25 6:00:12 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $33,750 worth of shares (5,000 units at $6.75), increasing direct ownership by 3% to 166,857 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/23/25 4:01:25 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    SEC Filings

    View All

    SEC Form 144 filed by Herbalife Ltd.

    144 - HERBALIFE LTD. (0001180262) (Subject)

    5/11/26 4:12:44 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Ltd. filed SEC Form 8-K: Results of Operations and Financial Condition, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - HERBALIFE LTD. (0001180262) (Filer)

    5/6/26 4:28:47 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form 10-Q filed by Herbalife Ltd.

    10-Q - HERBALIFE LTD. (0001180262) (Filer)

    5/6/26 4:23:43 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $HLF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $HLF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Herbalife Named to Three 2026 USA TODAY Most Trusted Brands Lists

    Recognitions reflect consumer confidence in the company's quality, reliability, and wellness leadership across generations Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, has been named to three 2026 USA TODAY Most Trusted Brands lists, including Most Trusted Brands, Brands Most Trusted by Parents, and Brands Most Trusted by Senior Citizens. The recognitions reflect consumer confidence in Herbalife's science-backed products and commitment to supporting healthy, active lifestyles across generations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603147461/en/Herbalife Named to Three

    6/3/26 4:30:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Chief Financial Officer to Present at East Coast IDEAS Conference on June 11

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced John DeSimone, Chief Financial Officer, will present at the East Coast IDEAS Conference on Thursday, June 11, 2026 at 10:35 a.m. ET (7:35 a.m. PT). The live webcast will be available at the following link: https://event.summitcast.com/view/GAjb2PfaSPbv9ViGy3AtzN/ZC5vwyKUXDsTKS4G6iXFet A link to the webcast will also be available under the Investor Relations section of Herbalife's website at https://ir.herbalife.com/. A replay of the webcast will be available at the same website following the completion of the event and for six months thereafter. Additional information regarding th

    6/2/26 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Roman DBDR Acquisition Corp. II Appoints Hunter Gary to Board of Directors and Al Basseri as Chief Technology Officer, Ahead of Proposed Business Combination with ThomasLloyd Climate Solutions

    Roman DBDR Acquisition Corp. II ("Roman DBDR" or the "Company") (NASDAQ:DRDB) today announced the appointment of Hunter Gary to its Board of Directors (the "Board") and Al Basseri as Chief Technology Officer, as the Company continues preparations to complete its previously announced business combination with ThomasLloyd Climate Solutions B.V. ("ThomasLloyd"), a vertically integrated sustainable energy and technology solutions provider (the "Proposed Business Combination"). "We are thrilled to welcome Hunter to the Board of Directors and Al as our Chief Technology Officer as we prepare to complete our business combination with ThomasLloyd," said Dixon Doll, Jr., Chairman and CEO of Roman D

    5/15/26 8:00:00 AM ET
    $AEP
    $CVI
    $DRDB
    Electric Utilities: Central
    Utilities
    Integrated oil Companies
    Energy

    Maxim Group initiated coverage on Herbalife Nutrition with a new price target

    Maxim Group initiated coverage of Herbalife Nutrition with a rating of Buy and set a new price target of $20.00

    1/6/26 9:08:50 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Nutrition upgraded by Argus

    Argus upgraded Herbalife Nutrition from Hold to Buy

    11/26/25 7:50:23 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Nutrition upgraded by DA Davidson with a new price target

    DA Davidson upgraded Herbalife Nutrition from Neutral to Buy and set a new price target of $14.00 from $7.50 previously

    3/21/25 8:38:07 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Amendment: New insider Walsh Des claimed ownership of 50,000 shares (SEC Form 3)

    3/A - HERBALIFE LTD. (0001180262) (Issuer)

    5/20/26 8:49:59 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Chief Operating Officer Hicks Troy sold $619,556 worth of shares (48,377 units at $12.81), exercised 83,270 shares at a strike of $9.31 and covered exercise/tax liability with 72,626 shares, decreasing direct ownership by 80% to 9,706 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/20/26 8:50:19 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Chief Commercial Officer Lamberti Frank sold $1,932,259 worth of shares (142,919 units at $13.52), decreasing direct ownership by 80% to 36,624 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/12/26 9:59:12 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Leadership Updates

    Live Leadership Updates

    View All

    Herbalife to Expand Its Personalized Nutritional Supplement Capabilities Through Planned Acquisition of Bioniq

    Transaction accelerates Herbalife and Cristiano Ronaldo's commitment to scale personalized nutrition and wellness globally Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced an agreement to acquire certain assets from Bioniq, a UK-based personalized supplements company focused on making health more accessible and actionable. The transaction advances Herbalife's vision of becoming a technology-enabled, data-driven health and wellness platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260326423343/en/Herbalife to Expand Its Personalized Nutritional Supplement Capabilit

    3/26/26 6:30:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Welcomes Lynda Cloud to its Board of Directors

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced the election of Lynda Cloud to its Board of Directors, effective April 23, 2025. This appointment reflects Herbalife's continued commitment to innovation, digital transformation, and personalized wellness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425107883/en/Herbalife Welcomes Lynda Cloud to the Board of Directors Lynda Cloud's decades of leadership across education, technology, and health sectors make her uniquely equipped to support Herbalife's next chapter. Her deep expertise in digital learning, consumer experie

    4/25/25 5:12:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Appoints Stephan Gratziani as Chief Executive Officer

    Current CEO Michael Johnson Transitions to Executive Chairman Herbalife Ltd. (NYSE:HLF) today announced its Board of Directors has appointed President, Stephan Gratziani as Chief Executive Officer (CEO) effective May 1, 2025. Michael Johnson, current CEO and Chairman of the Board, will transition to Executive Chairman. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250219653469/en/Herbalife appoints Stephan Gratziani as Chief Executive Officer (Photo: Business Wire) As a former Herbalife independent distributor, Mr. Gratziani built and grew his international business into one of the top global distributorships. For 32 years, he

    2/19/25 4:05:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Financials

    Live finance-specific insights

    View All

    $HLF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Herbalife Reports First Quarter 2026 Net Sales Growth and Adjusted EBITDA1 Above Guidance; Raises Full-Year 2026 Constant Currency2 Net Sales and Adjusted EBITDA1 Guidance Midpoints

    Q1 Results in Line with Preliminary Results Announced on April 14 Herbalife Ltd. (NYSE:HLF) today reported financial results for the first quarter ended March 31, 2026: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260506758807/en/ "We delivered strong Q1 results that exceeded guidance and we successfully completed our debt refinancing. At the same time, we took further strategic actions to build on Herbalife's deep-rooted strength in personalization, enhance speed to market capabilities, and position us for long-term growth and value creation." - Stephan Gratziani, CEO Highlights First Quarter 2026 Net sales of $1.3

    5/6/26 4:10:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Provides Preliminary Q1 2026 Results: Net Sales Above Guidance, Adjusted EBITDA1 Expected At or Above High End of Guidance; Provides Update on Senior Secured Debt Refinancing Plans

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced preliminary first quarter 2026 results. The Company expects: Net sales growth of 7.5% to 8.0% year-over-year, exceeding the high end of previously issued first quarter guidance Net sales growth on a constant currency basis2 of 5.0% to 5.5% year-over-year, above the high end of previously issued first quarter guidance; and Adjusted EBITDA¹ on a reported basis at or above the high end of previously issued first quarter guidance First quarter 2026 guidance for each metric was previously issued on February 18, 2026. The Company's first quarter net sales outperformance was driv

    4/14/26 8:00:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife to Announce First Quarter 2026 Results on May 6

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its first quarter 2026 financial results after the close of trading on the NYSE on Wednesday, May 6, 2026. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host an audio webcast and conference call to discuss its recent financial results. The audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/udjduiru Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register-conf.media-server.com/register/BIe9234

    4/1/26 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Amendment: SEC Form SC 13G/A filed by Herbalife Ltd.

    SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

    11/14/24 4:11:11 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G filed by Herbalife Ltd.

    SC 13G - HERBALIFE LTD. (0001180262) (Subject)

    11/13/24 4:01:31 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Amendment: SEC Form SC 13G/A filed by Herbalife Ltd.

    SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

    11/13/24 12:49:27 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care